RE:RE:RE:RE:On GLP-1 agonists US Senate passes anti-patent thicket billAugust 28, 2024 - The USPTO’s May 2024 proposed anti-patent thicket rule, which promotes competition by lowering the cost of challenging groups of patents linked by terminal disclaimers, is also proposed to result in reduced barriers to market entry. Under the proposed USPTO rule, “if you invalidate one, the whole thing falls,”
On the legislative side, currently there are two major bipartisan bills working their way through Congress which seek to curb Big Pharma’s manipulation of the patent system, by filing multiple follow-on patents on variations of the same technology. Commony known as "evergreening".
https://www.biospace.com/policy/patent-thickets-in-federal-governments-crosshairs-as-election-2024-looms